收费全文 | 10160篇 |
免费 | 769篇 |
国内免费 | 909篇 |
2024年 | 14篇 |
2023年 | 141篇 |
2022年 | 347篇 |
2021年 | 545篇 |
2020年 | 359篇 |
2019年 | 442篇 |
2018年 | 405篇 |
2017年 | 320篇 |
2016年 | 472篇 |
2015年 | 623篇 |
2014年 | 777篇 |
2013年 | 816篇 |
2012年 | 952篇 |
2011年 | 921篇 |
2010年 | 536篇 |
2009年 | 493篇 |
2008年 | 538篇 |
2007年 | 515篇 |
2006年 | 432篇 |
2005年 | 337篇 |
2004年 | 255篇 |
2003年 | 292篇 |
2002年 | 207篇 |
2001年 | 165篇 |
2000年 | 147篇 |
1999年 | 151篇 |
1998年 | 91篇 |
1997年 | 74篇 |
1996年 | 90篇 |
1995年 | 66篇 |
1994年 | 44篇 |
1993年 | 33篇 |
1992年 | 55篇 |
1991年 | 40篇 |
1990年 | 26篇 |
1989年 | 33篇 |
1988年 | 13篇 |
1987年 | 19篇 |
1986年 | 13篇 |
1985年 | 14篇 |
1984年 | 9篇 |
1983年 | 11篇 |
1982年 | 3篇 |
1981年 | 1篇 |
1980年 | 1篇 |
Soybean has a palaeopolyploid genome with nearly 75% of the genes present in multiple copies. Although the CRISPR/Cas9 system has been employed in soybean to generate site-directed mutagenesis, a systematical assessment of mutation efficiency of the CRISPR/Cas9 system for the multiple-copy genes is still urgently needed. Here, we successfully optimize one sgRNA CRISPR/Cas9 system in soybean by testing the efficiency, pattern, specificity of the mutations at multiple loci of GmFAD2 and GmALS. The results showed that simultaneous site-directed mutagenesis of two homoeologous loci by one sgRNA, the mutation frequency in the T0 generation were 64.71% for GmPDS, 60.0% for GmFAD2 and 42.86% for GmALS, respectively. The chimeric and heterozygous mutations were dominant types. Moreover, association of phenotypes with mutation pattern at target loci of GmPDS11 and GmPDS18 could help us further demonstrate that the CRISPR/Cas9 system can efficiently generate target specific mutations at multiple loci using one sgRNA in soybean, albeit with a relatively low transformation efficiency.
相似文献The expression of IL-2RA and IL-2RB was correlated with breast cancer (BC) progression. However, there is no literature investigating the association of IL-2RA and IL-2RB polymorphisms with BC predisposition among Chinese Han Women. Seven SNPs in IL-2RA and IL-2RB were genotyped by Agena MassARRAY platform among 553 BC patients and 550 healthy controls. Odds ratios (OR) and 95% confidence interval (CI) adjusted for age were calculated for the effect of IL-2RA and IL-2RB variants on BC susceptibility. IL-2RA rs12722498 was a protective factor for BC occurrence (OR?=?0.70, p?=?0.019), especially in subjects with age?≤?52 years (OR?=?0.55, p?=?0.004). IL-2RA rs12569923 (OR?=?9.07, p?=?0.033), IL-2RB rs2281089 (OR?=?0.67, p?=?0.043) and rs9607418 (OR?=?0.59, p?=?0.012) were related to the incidence of estrogen receptor positive (ER?+) BC. IL-2RB rs3218264 (OR?=?1.38, p?=?0.010) and rs9607418 (OR?=?0.56, p?=?0.009) were associated with the risk of developing progesterone receptor positive (PR?+) BC. Rs2281089 (OR?=?1.54, p?=?0.012) and rs1573673 (OR?=?0.72, p?=?0.035) were correlated to Ki-67 level. Moreover, IL-2RB rs2281089 (OR?=?0.72, p?=?0.022) showed a reduced risk of BC metastasis, and IL-2RA rs12722498 (OR?=?0.54, p?=?0.030) had a lower frequency in BC patients with tumor size?>?2 cm. Our study identified the potential effect of genetic variations in IL-2RA and IL-2RB on BC susceptibility and/or BC clinicopathologic indicators among Chinese Han Women.
相似文献